Literature DB >> 9367992

A family of putative tumor suppressors is structurally and functionally conserved in humans and yeast.

L Li1, B R Ernsting, M J Wishart, D L Lohse, J E Dixon.   

Abstract

In Saccharomyces cerevisiae the CDC14 gene is essential for cell cycle progression. Strains carrying the cdc14-1(ts) allele enter the cell cycle and arrest at restrictive temperatures. We have identified two human cDNAs encoding proteins which share sequence identity to the yeast CDC14p. The cell cycle arrest in cdc14-1(ts) can be specifically complemented by the human cDNAs suggesting that they are functionally equivalent to the yeast CDC14 gene. Another clone identified in the search for human CDC14-like proteins corresponded to the putative tumor suppressor gene PTEN/MMAC1 (phosphatase and tensin homologue deleted on chromosome 10 or mutated in multiple advanced cancers 1). Analysis of the PTEN/MMAC1 showed that it did not complement the cdc14-1(ts) allele and that it is more closely related to the yeast open reading frame YNL128W. Human CDC14p and PTEN/MMAC1 were expressed as recombinant proteins, and both were shown to have kinetic properties characteristic of dual specific phosphatases. The human CDC14p was localized in the nucleus while PTEN/MMAC1 has been reported to be localized in the cytoplasm. Our results suggest that CDC14 and YNL128W/PTEN/MMAC1 represent two related, but distinct, families of human and yeast phosphatases.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9367992     DOI: 10.1074/jbc.272.47.29403

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  53 in total

1.  Akt-mediated survival of oligodendrocytes induced by neuregulins.

Authors:  A I Flores; B S Mallon; T Matsui; W Ogawa; A Rosenzweig; T Okamoto; W B Macklin
Journal:  J Neurosci       Date:  2000-10-15       Impact factor: 6.167

Review 2.  Dial 9-1-1 for p53: mechanisms of p53 activation by cellular stress.

Authors:  M Ljungman
Journal:  Neoplasia       Date:  2000 May-Jun       Impact factor: 5.715

3.  Role for human SIRT2 NAD-dependent deacetylase activity in control of mitotic exit in the cell cycle.

Authors:  Sylvia C Dryden; Fatimah A Nahhas; James E Nowak; Anton-Scott Goustin; Michael A Tainsky
Journal:  Mol Cell Biol       Date:  2003-05       Impact factor: 4.272

4.  Cdc14 phosphatases preferentially dephosphorylate a subset of cyclin-dependent kinase (Cdk) sites containing phosphoserine.

Authors:  Steven C Bremmer; Hana Hall; Juan S Martinez; Christie L Eissler; Thomas H Hinrichsen; Sandra Rossie; Laurie L Parker; Mark C Hall; Harry Charbonneau
Journal:  J Biol Chem       Date:  2011-11-23       Impact factor: 5.157

Review 5.  How to divorce engaged chromosomes?

Authors:  Rolf Jessberger
Journal:  Mol Cell Biol       Date:  2005-01       Impact factor: 4.272

6.  The dual-specificity phosphatase CDC14B bundles and stabilizes microtubules.

Authors:  Hyekyung P Cho; Yie Liu; Marla Gomez; John Dunlap; Mike Tyers; Yisong Wang
Journal:  Mol Cell Biol       Date:  2005-06       Impact factor: 4.272

7.  Cell cycle arrest and apoptosis by expression of a novel TPIP (TPIP-C2) cDNA encoding a C2-domain in HEK-293 cells.

Authors:  Rasmi Rekha Mishra; Jitendra Kumar Chaudhary; Pramod C Rath
Journal:  Mol Biol Rep       Date:  2012-02-07       Impact factor: 2.316

Review 8.  Phosphatases: providing safe passage through mitotic exit.

Authors:  Claudia Wurzenberger; Daniel W Gerlich
Journal:  Nat Rev Mol Cell Biol       Date:  2011-07-13       Impact factor: 94.444

9.  Platelet-derived growth factor-BB-mediated glycosaminoglycan synthesis is transduced through Akt.

Authors:  Nicholas J Cartel; Jinxia Wang; Martin Post
Journal:  Biochem J       Date:  2002-04-01       Impact factor: 3.857

10.  Polo-like kinase-1 controls Aurora A destruction by activating APC/C-Cdh1.

Authors:  Renske van Leuken; Linda Clijsters; Wouter van Zon; Dan Lim; XueBiao Yao; Rob M F Wolthuis; Michael B Yaffe; René H Medema; Marcel A T M van Vugt
Journal:  PLoS One       Date:  2009-04-23       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.